Key Takeaways
- Marvell (MRVL) shares climbed more than 4% Monday following news that Nvidia’s Kyber NVL144 system encounters significant production challenges, delaying its rollout until 2028.
- According to SemiAnalysis, Nvidia has also scrapped its NVL72x2 dual-rack configuration after receiving negative feedback from major cloud platforms and hyperscalers.
- These obstacles have left Nvidia struggling to find viable scaling solutions for its Rubin Ultra processor, potentially benefiting competitors like Marvell.
- The company delivered Q1 revenue of $2.42 billion, representing a 27.6% annual increase, with earnings per share of $0.80 aligning with expectations. Q2 EPS is projected between $0.88 and $0.98.
- Wall Street maintains a consensus “Moderate Buy” rating on MRVL, with analyst price targets reaching as high as $345, while institutional stakeholders control 83.51% of shares.
Shares of Marvell Technology (MRVL) climbed approximately 4.37% to $256.00 during Monday’s premarket session, following a report from SemiAnalysis revealing significant production setbacks for Nvidia’s Kyber NVL144 AI hardware platform.
Marvell Technology, Inc., MRVL
The analysis, published Sunday via X, indicated that the Kyber NVL144 configuration has encountered substantial manufacturing obstacles merely three months following its unveiling by Nvidia CEO Jensen Huang at GTC. The system’s commercial availability has reportedly been pushed back over a year, with deployment now anticipated in 2028.
SemiAnalysis identified two critical bottlenecks: complications with the PCB midplane design and hurdles related to co-packaged optics (CPO) implementation.
Adding to Nvidia’s challenges, the company has abandoned its contingency strategy. The NVL72x2 dual-rack configuration, designed to enhance copper NVLink capabilities through stacked Oberon racks, was discontinued after major cloud infrastructure providers rejected the architecture due to its excessive complexity and operational requirements.
These combined obstacles have left Nvidia without viable pathways to expand capacity for its forthcoming Rubin Ultra processor. SemiAnalysis noted this situation presents opportunities for competing platforms, specifically mentioning AMD’s MI500X and Google’s TPUv8i Broadfly as potential gainers. Reports also indicate cancellation of the 4-compute-die Rubin Ultra variant.
For Marvell, these developments arrive at an opportune moment. The semiconductor firm has been strengthening its position as an alternative AI infrastructure supplier, with particular emphasis on optical networking solutions. CNBC’s Jim Cramer recently spotlighted Marvell’s industry position, echoing Huang’s previous forecast that Marvell could eventually achieve a trillion-dollar market valuation.
Financial Performance Overview
Marvell released its Q1 results on May 27. The company generated $2.42 billion in revenue, marking a 27.6% year-over-year increase, while earnings per share of $0.80 precisely met consensus projections. Management provided Q2 2027 EPS guidance of $0.88 to $0.98. Analysts are forecasting full-year EPS of $3.07.
The company also declared a quarterly dividend distribution of $0.06 per share, scheduled for July 30 payment to shareholders of record on July 10. This translates to an annualized dividend yield of approximately 0.1%.
MRVL stock trades within a 52-week range of $61.44 to $329.88, with a current market capitalization near $214.58 billion. Shares commenced Monday’s session at $245.29.
Investment Community Outlook
Institutional investors hold 83.51% of outstanding shares. Multiple institutional funds expanded their positions during Q1 and Q2. Elevation Point Wealth Partners nearly doubled its holdings, increasing 98.2% to 15,828 shares. Baird Financial Group expanded its stake by 22.7% in Q2.
Analyst perspectives remain predominantly positive. B. Riley elevated its price objective from $240 to $345 while maintaining a Buy recommendation. Needham increased its target from $118 to $270, also with a Buy rating. William Blair reaffirmed its Outperform stance.
Among 37 analysts providing coverage, three assign a Strong Buy rating, 28 recommend Buy, and six rate it Hold. The consensus price target stands at $239.81.
Regarding insider transactions, CEO Matthew Murphy divested 7,500 shares at $177.26 in May, while CFO Daniel Durn sold 2,250 shares at $281.01 in June.
From a technical perspective, MRVL is experiencing a pullback within its broader upward trend. The stock trades 9.1% below its 20-day moving average of $282.05, yet remains 14.6% above the 50-day average at $223.63. The RSI indicator reads 46.40, suggesting neutral momentum conditions.


